isoselenocyanic-acid and selenourea

isoselenocyanic-acid has been researched along with selenourea* in 1 studies

Other Studies

1 other study(ies) available for isoselenocyanic-acid and selenourea

ArticleYear
New Organoselenium (NSAIDs-Selenourea and Isoselenocyanate) Derivatives as Potential Antiproliferative Agents: Synthesis, Biological Evaluation and in Silico Calculations.
    Molecules (Basel, Switzerland), 2022, Jul-06, Volume: 27, Issue:14

    In this study, we report on the synthesis of new organoselenium derivatives, including nonsteroidal anti-inflammatory drugs (NSAIDs) scaffolds and Se functionalities (isoselenocyanate and selenourea), which were evaluated against four types of cancer cell line: SW480 (human colon adenocarcinoma cells), HeLa (human cervical cancer cells), A549 (human lung carcinoma cells), MCF-7 (human breast adenocarcinoma cells). Among these compounds, most of the investigated compounds reduced the viability of different cancer cell lines. The most promising compound

    Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Drug Screening Assays, Antitumor; Humans; Molecular Docking Simulation; Molecular Structure; Organoselenium Compounds; Structure-Activity Relationship; Urea

2022